ASH
December 18, 2020
62nd American Society of Hematology (ASH) Annual Meeting and Exposition, December 5-8, 2020
Year
2020
Target
daposertib (MEN1703 / SEL24), PIM/FLT3
Assets in this page
Download assets
- pdf file
"SEL24/MEN1703 provides PIM/FLT3 Downstream Pathway Inhibition in Acute Myeloid Leukemia (AML) Blast Cells: Results of the Pharmacodynamic (PD) Assay in the Dose Escalation Part of First-in-Human DIAMOND-01 Trial"
Download - pdf file
"PIM Kinase Inhibition Decreases the Proangiogenic Properties of Multiple Myeloma Cells and Affects the Metabolic State of the Vascular Endothelium"
Download